Navigation Links
Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
Date:9/13/2007

r all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward- looking statements. Furthermore, Cephalon does not intend to update publicly any forward-looking statement, except as required by law. The Private Securities Litigation Reform Act of 1995 permits this discussion.


'/>"/>
SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Rapid SNP Genotyping of the Pharmacogenomically Important Allele CYP2D6*4 Using Real-Time qPCR on the DNA Engine Opticon 2 System
2. Why IT change management is more important than ever
3. Contrary to popular belief, holidays are an important time to network
4. Californians: Stem cells important enough to go into debt for
5. The use of e-prescribing and electronic health records is accelerating
6. Imaging and Analysis of DIGE Product Information Sheet, Rev B
7. Study affirms information technology-productivity link
8. TrafficCast integrates new information source
9. Rote education fails the Information Age
10. Weather information companies launch data product
11. TeraMedica launches information manager

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...Colo., Nov. 5 The endangered black...estern U.S. This rare carnivore feeds on prairie ...lague and often entire population die-offs in town...S) has implemented a ferret breeding program and h...eir formerly native habitat. Unfortunately, plagu...
(Date:11/5/2009)...ov. 5 Imagenetix, Inc. (...lliam Spencer, President and CEO of Imagenetix, wi...nual LD MICRO Conference on Thursday, December 3rd...s. ,, About LD MICRO ,, LD MICRO is a by-inv...ng undervalued companies in the micro-cap space. S...
(Date:11/5/2009)...all on Thursday, November 5, 2009 at 4:30 p.m. Eas.../PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals...XI ) today reported unaudited financial results fo...r 30, 2009 and reviewed the Company,s highlights f...consolidated results reflect the operations of Onc...
(Date:11/5/2009)...Y., Nov. 5 BioSpecifics ...utical company developing first-in-class collagena...esults for the third quarter ended September 30, 2...ember of this year, the FDA,s Arthritis Advisory C...0, the approval of XIAFLEX(TM) for the treatment o...
Breaking Biology Technology:Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5
...s Pharma, the,Danish biopharmaceutical company dev...at Keith McCullagh, President and Chief Executive,...pany and its goals for,2008 at the Biotechnology I...Conference in New York, today, Monday February 11t...ral European Time). The conference is,being held a...
...28, The Royal,Marsden Hospital (Sutton, Surrey, UK...lated Arc Therapy (VMAT)* treatment in the world u...e the treatment, the hospital,used its existing El...n,linear accelerator control system., (Logo: htt...GO ), VMAT takes Intensity Modulated Radiation T...
...0 Doses of the CDC,s National Strategic...OLIS, Feb. 11 Sentry Logistic Solutions,announced...ention (CDC),signed a contract to outsource storag...ve of the influenza virus vaccine. Sentry will war...ses from its pharmaceutical cold,chain logistics c...
Other Biology Technology:Santaris Pharma to Present at 10th Annual Biotechnology Industry Organisation CEO & Investor Conference - February 11th, 2008 2Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital 2The Centers for Disease Control & Prevention Signs Vaccine Storage and Distribution Contract with Sentry Logistic Solutions 2The Centers for Disease Control & Prevention Signs Vaccine Storage and Distribution Contract with Sentry Logistic Solutions 3
(Date:11/5/2009)...hers (NABT) will recognize Leonard C. Yannielli, p...y Community College (NVCC) in Waterbury, Connectic... the NABT annual professional development conferen...ado. , The Evolution Education Award is cosponso...es,(AIBS) and Biological Sciences Curriculum Stud...
(Date:11/4/2009)...luctant to officially endorse green tea as a cance...out its protective effects, including results of a...h , a journal of the American Association for Canc... cancer. , Vassiliki Papadimitrakopoulo, M.D., ...c/Head and Neck Medical Oncology at the University...
(Date:11/4/2009)...od obesity in the United States is reaching epidem...tising on daytime and prime time television devote...about the role television plays in obesity, a stud...f Nutrition Education and Behavior examines how f... contributor to the problem. , Researchers at th...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium 13511 1Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium 13511 2Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium 13511 3VIVUS Reports Second Quarter 2009 Financial Results 54258 1VIVUS Reports Second Quarter 2009 Financial Results 54258 2VIVUS Reports Second Quarter 2009 Financial Results 54258 3VIVUS Reports Second Quarter 2009 Financial Results 54258 4VIVUS Reports Second Quarter 2009 Financial Results 54258 5VIVUS Reports Second Quarter 2009 Financial Results 54258 6VIVUS Reports Second Quarter 2009 Financial Results 54258 7Ohio Judge Rules Tobacco Settlement Funds Should Be Used as Intended to Reduce Tobacco Use and Save Lives 54255 1Ohio Judge Rules Tobacco Settlement Funds Should Be Used as Intended to Reduce Tobacco Use and Save Lives 54255 2
...r gene has been discovered by scientists at the Lu...tic Surgery Clinic at the Sahlgrenska Academy in S...tain hereditary deformity syndrome run a nearly tw...r than expected. , Several research teams around ...ary breast cancer genes, but thus far few have bee...
...ng Project, funded by the National Institute of Al...National Institutes of Health (NIH), announced tod...ire genetic blueprints of more than 2,000 human an...d the world have been completed and the sequence d...information will help scientists understand how in...
...of York have won a grant of £110,000 to investigat...sease. , Dr Jason Lynam and Dr Ian Fairlamb, of t... awarded the funding by the Leverhulme Trust for a...for the controlled release of carbon monoxide into...inflammatory, and they want to explore its potenti...
Other Biology News:New hereditary breast cancer gene discovered 22,000 influenza virus genomes now completed and publicly accessible 2Research to spotlight carbon monoxide benefits 2
Rat Anti-Mouse Activin RIB / ALK-4 Monoclonal Antibody, Unconjugated, Clone 207304 from R&D Systems
Normal Human Serum from 3H Biomedical AB
...ns oligos for SYBR Green, TaqMan, LNA spiked TaqMa...says. Highly specific primers are designed by avoi...preting BLAST search results. Primer efficiency is...s identified by connecting to the Mfold server. Be...
Agar (BACTERIOLOGICAL GRADE) from GE Healthcare, formerly Amersham Biosciences
Biology Products: